NIH R01 Winners: 3,442 New Awards in FY2025

According to NIH, the R01 activity code (opens in a new tab) supports a discrete research project performed by named investigators. NIH describes R01 as its most common independent research-project grant. NIH RePORTER (opens in a new tab) provides the public project numbers, recipients, investigators, award amounts, fiscal years, and administering institutes used here.

The phrase "NIH R01 winners" needs a clear unit. A Type 1 project number identifies a new application. Type 2 identifies a renewal. Type 5 identifies a noncompeting continuation, usually a later funded year of an existing project. Treating all project-year rows as new winners would overstate the result by more than seven times.

What NIH R01 Winners Means in RePORTER

NIH's current application-type definitions (opens in a new tab) provide the key:

The July 29 pull also found 1,365 Type 3 revisions, 537 Type 4 extensions, 473 Type 7 recipient changes, 14 Type 9 institute changes, and 2 Type 6 organization-status changes. These records belong in the complete R01 history, but they should not be labeled new winners.

RePORTER data can be backfilled after an initial fiscal-year release. Compared with the prior June snapshot, the current API returned 195 more FY2025 rows and 286 more FY2024 rows. That is why this page reports its retrieval date and why the collector verifies exact coverage on every run.

Next route: Compare this history with the NIH R01 guide, NIH R01 success-rate data, NIH grants guide, R01/R21/R03/K comparison, parent R01 no-trial record, parent R01 trial-required record, and the free Grantsights grant search.

10 High-Award New FY2025 R01 Records

The table below is limited to Type 1 new awards. It does not mix later-year continuations into the winner preview.

These are extreme rows, not a normal budget target. Across all 3,442 Type 1 new awards, the median total award amount was $676,197 and the average was $849,346. The gap between the median and average shows how high-cost clinical, network, longitudinal, and consortium work pulls the mean upward.

For example, Lighthouse Pharmaceuticals received the largest Type 1 award in this FY2025 pull at $12,591,952. That one record is more than 18 times the $676,197 new-award median. It is useful as a real winner record, but it is a poor starting point for a typical applicant's budget.

NIH explains on the R01 activity-code page that allowable costs can include salary, equipment, supplies, consultants, publications, contracts, consortium costs, facilities and administrative costs, and travel. A RePORTER total-cost amount does not create permission to request that budget. The selected notice and institute policy control the application.

FY2024 to FY2025 R01 Award-History Movement

According to NIH's FY2025 By the Numbers (opens in a new tab), NIH received 42,022 R01-equivalent applications and made 5,471 competing R01-equivalent awards. According to the same NIH report, the R01-equivalent success rate was 13.0% and the average award was $664,005.

Those figures do not conflict with the RePORTER table. They measure different things:

Do not divide the 3,442 Type 1 R01 records by the 42,022 R01-equivalent applications. The numerator covers the R01 activity code, while the denominator belongs to NIH's wider R01-equivalent group.

Top R01 States and NIH Institutes

The state table is a capacity signal, not an odds table. California's 3,695 records show a large public R01 footprint. They do not show that a California PI has an easier review. Compare organizations with a similar research setting, project scale, institute, and review home.

Institute choice changes the useful comparison. NCI, NHLBI, and NIAID each had more than 3,000 FY2025 R01 project-year records, but they do not share identical missions, notices, trial requirements, review patterns, or budget policies. Search the target institute and the current notice, not only the activity code.

Top FY2025 R01 Recipient Organizations

This concentration shows why environment evidence matters. A smaller institution can compete, but the application must make access, collaborators, facilities, recruitment, samples, methods, and data support easy to assess. Recipient volume alone does not decide scientific merit.

R01 Fit Decision Checklist

R01 award history is useful only if it changes an apply, wait, skip, or route decision.

A similar funded title is weak evidence by itself. Stronger evidence includes method readiness, access to participants or samples, an analysis plan, team coverage, budget logic, and a review home that matches the work.

Write one route sentence before the aims page: "This is an R01 because the project is mature, independent, multi-year, and needs full research-project support." If that statement is not supported, compare a nearby route before assigning a full proposal team.

Apply, Wait, or Shift Routes

According to NIH's parent announcement listings (opens in a new tab), applicants still need the exact parent or institute-specific notice. A winner record proves what NIH funded. It does not prove that the same notice remains open or that the new project belongs in the same route.

What RePORTER Doesn't Tell You

The hard truth is that award history can make a weak route decision feel safer than it is. RePORTER cannot judge whether preliminary data support the premise, whether the clinical-trial designation is correct, whether a study section will understand the methods, or whether the target institute participates in the selected notice. The common mistake is to find a similar title and treat it as permission to write.

Start with Type 1 and Type 2 records, but avoid copying the largest budgets or assuming recipient concentration predicts individual odds. The strongest comparison set matches the scientific topic, institute, organization setting, project maturity, review area, and current notice. If those signals disagree, pause the R01 and compare another route.

What Official Sources Prove

Use RePORTER before drafting, not after. If funded comparisons cluster in another institute, mechanism, or review area, changing the route early costs less than reshaping a completed application.

Going Deeper With Free Tools

This page provides current winner counts, selected Type 1 records, award amounts, top states, top institutes, top recipients, and route-choice implications. For deeper institute slicing, topic comparisons, study-section research, adjacent-mechanism checks, or repeat-recipient analysis, use NIH RePORTER (opens in a new tab) directly: it's free and lets you filter by activity code, institute, study section, organization, and fiscal year. To find open NIH and other funding notices, use the free Grantsights grant search.

Sources

• NIH R01 activity code: grants.nih.gov (opens in a new tab)
• NIH application types: grants.nih.gov (opens in a new tab)
• NIH RePORTER search: reporter.nih.gov (opens in a new tab)
• NIH RePORTER API: api.reporter.nih.gov (opens in a new tab)
• NIH parent announcements: grants.nih.gov (opens in a new tab)
• NIH success-rate tables: report.nih.gov (opens in a new tab)
• NIH FY2025 By the Numbers: grants.nih.gov (opens in a new tab)
• NIH application guide: grants.nih.gov (opens in a new tab)

Related Guides

• NIH R01 research project grant
• NIH R01 success-rate data
• NIH grants complete guide
• NIH R21 award history
• NIH K01 award history
• NIH MIRA R35 award history
• NIH R01, R21, R03, and K awards comparison
• NIH K99/R00 award history
• NIH K08 award history
• NIH R15 AREA and REAP award history